Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
February 15th, 2024 |
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
National Institutes of Health |
February 16th, 2021 |
THRIVE Water Sanitation and Hygiene Activity |
Rwanda USAID Kigali |
July 25th, 2023 |
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
May 24th, 2021 |
Community Health Workers for COVID Response and Resilient Communities (CCR) |
Centers for Disease Control NCCDPHP |
September 12th, 2023 |
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional) |
National Institutes of Health |
February 26th, 2021 |
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
February 26th, 2021 |
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
June 1st, 2021 |
No Wrong Door Community Infrastructure Grants: Scaling Network Lead Entities |
Administration for Community Living |
March 24th, 2021 |
INTUIT-PC: Improving Nonsurgical Treatment of Urinary Incontinence among women in Primary Care: Dissemination and Implementation of PCOR Evidence (U18) |
Agency for Health Care Research and Quality |
February 15th, 2021 |
Resiliency In Communities After Stress and Trauma |
Substance Abuse and Mental Health Services Adminis |
February 15th, 2021 |
Enhancing Public Health Laboratory Capabilities and Increasing Capacity |
Centers for Disease Control CSELS |
October 26th, 2023 |
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
National Institutes of Health |
February 5th, 2021 |
PEPFAR Community-Led Monitoring Program |
US Mission to Angola |
February 22nd, 2021 |
Primary Care Training and Enhancement-Community Prevention and Maternal Health (PCTE-CPMH) |
Health Resources and Services Administration |
February 10th, 2021 |
Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
April 19th, 2021 |
Core State Injury Prevention Program (Core SIPP) |
Centers for Disease Control NCIPC |
May 31st, 2021 |
Strengthening Rocky Mountain spotted fever (RMSF) prevention and control in Arizona tribal lands |
Centers for Disease Control NCEZID |
January 7th, 2024 |
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) |
National Institutes of Health |
February 17th, 2021 |
Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 15th, 2021 |
Native Hawaiian Health Care Improvement Act |
Health Resources and Services Administration |
|
February 12th, 2021 |
Health Services Quality Accelerator (HSQA) |
Jordan USAID Amman |
October 17th, 2023 |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
October 10th, 2023 |
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) |
National Institutes of Health |
January 7th, 2024 |
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
National Institutes of Health |
October 17th, 2023 |
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) |
National Institutes of Health |
February 11th, 2021 |
Support of Global Polio Eradication Initiative (GPEI) using Integrated Modeling |
Centers for Disease Control CGH |
March 25th, 2021 |
Development of Methods to Evaluate the Impact of Design Differences to the User Interface of Generic Drug-Device Combination Products in Comparison to their Reference Listed Drugs (U01) Clinical Trials Optional |
Food and Drug Administration |
July 8th, 2021 |
Virtual Approaches Towards New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (U18 Clinical Trials Not Allowed) |
National Institutes of Health |
July 8th, 2021 |
New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program (UG3/UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
June 15th, 2021 |
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
May 11th, 2021 |
NIAMS Centers of Research Translation (CORT) (P50 - Clinical Trial Not Allowed) |
National Institutes of Health |
March 29th, 2021 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R41 Clinical Trial Not Allowed) |
National Institutes of Health |
March 29th, 2021 |
Application of Artificial Intelligence and Machine Learning for Advancing Environmental Health Sciences (R43 Clinical Trial Not Allowed) |
National Institutes of Health |
February 18th, 2021 |
Physiologically-based pharmacokinetic (PBPK) models to aid the development of generic dermatological products (U01) Clinical Trials Optional |
Food and Drug Administration |
March 18th, 2021 |
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) |
National Institutes of Health |
June 11th, 2021 |
Drug Development Tools Research Grants (U01 Clinical Trial Optional) |
Food and Drug Administration |
January 22nd, 2021 |
Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning |
Food and Drug Administration |
May 25th, 2023 |
Research Experiences in Genomic Research for Data Scientists (R25) |
National Institutes of Health |
May 25th, 2023 |
Mentored Research Experiences for Genetic Counselors (R25) |
National Institutes of Health |
January 4th, 2021 |
Partnering with National Organizations to Increase Vaccination Coverage Across Different Racial and Ethnic Adult Populations Currently Experiencing Disparities |
Centers for Disease Control NCIRD |